World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
158
Citations
112081
World Ranking
835
National Ranking
476

Overview

Shaji Kumar is a researcher primarily affiliated with the Mayo Clinic in the United States. Their work focuses extensively on hematology and oncology, with a particular emphasis on multiple myeloma research and treatment.

Their research contributions cover multiple fields, predominantly medicine and biochemistry, genetics, and molecular biology. Within these broader areas, subfields include hematology, molecular biology, oncology, genetics, and immunology.

Kumar has been involved in numerous studies published in various academic journals. Frequent publication venues for their work include Blood, Blood Cancer Journal, Journal of Clinical Oncology, American Journal of Hematology, and Leukemia.

Key topics addressed in their research encompass:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Peptidase Inhibition and Analysis
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Cancer Treatment and Pharmacology

Their recent notable publications include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms, 2022, Leukemia
  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial, 2020, The Lancet Oncology
  • Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial, 2021, The Lancet Oncology
  • Multiple myeloma current treatment algorithms, 2020, Blood Cancer Journal

Throughout their career, Kumar has collaborated extensively with other researchers. Frequent co-authors include S. Vincent Rajkumar, Angela Dispenzieri, Morie A. Gertz, Prashant Kapoor, and Taxiarchis Kourelis.

Best Publications

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study

    Ola Landgren;Robert A. Kyle;Ruth M. Pfeiffer;Jerry A. Katzmann

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

    Jonathan J. Keats;Rafael Fonseca;Marta Chesi;Roelandt Schop

  • Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Philippe Moreau;Tamás Masszi;Norbert Grzasko;Nizar J Bahlis

  • EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

    J J M van Dongen;L Lhermitte;S Böttcher;J Almeida

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes

    Giovanni Palladini;Angela Dispenzieri;Morie A. Gertz;Shaji Kumar

  • Mesenteric venous thrombosis.

    Shaji Kumar;Michael G. Sarr;Patrick S. Kamath

  • Multiple Myeloma: Diagnosis and Treatment

    S. Vincent Rajkumar;Shaji Kumar

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

    S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri

  • Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.

    Thierry Facon;Shaji Kumar;Torben Plesner;Robert Z Orlowski

  • Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

    V H J van der Velden;A Hochhaus;G Cazzaniga;T Szczepanski

  • Clonal competition with alternating dominance in multiple myeloma

    Jonathan J. Keats;Marta Chesi;Jan B. Egan;Victoria M. Garbitt

  • Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Antonio Palumbo;Sara Bringhen;Maria Victoria Mateos;Alessandra Larocca

  • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

    Rob Pieters;Martin Schrappe;Paola De Lorenzo;Ian Hann

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

Frequent Co-Authors

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The path to a medical career is diverse, with several online degrees and certifications offering flexible, affordable options. For those seeking a quicker entry into healthcare, lpn program options online can lead to practical nursing roles within a year, providing essential patient care experience.

For registered nurses considering specialization, psych np programs offer a pathway to advanced practice in psychiatric and mental health settings, addressing a growing area of need.

Not all healthcare roles require direct patient care. Those interested in leadership may consider an affordable healthcare administration degree online, which opens doors to hospital management and policy positions. For graduate-level advancement, the most affordable mha programs can help deepen your expertise and increase your career potential in healthcare administration.

Exploring these varied online programs can help you find the best fit for your career goals—whether in direct care or healthcare leadership—while accommodating busy schedules and financial considerations.

Best Scientists Citing Shaji Kumar

Trending Scientists